Combination of biological and morphological parameters for the selection of patients with hepatocellular carcinoma waiting for liver transplantation

Clinical Transplantation

Volumn 26, Issue 2, 2012, Pages

  Lai, Quirino ^a   Avolio, Alfonso W ^b   Manzia, Tommaso M ^c   Sorge, Roberto ^d   Agnes, Salvatore ^b   Tisone, Giuseppe ^c   Berloco, Pasquale B ^a   Rossi, Massimo ^a  

^a POLICLINICO UMBERTO I   (Italy)

^b FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

^c TOR VERGATA UNIVERSITY HOSPITAL   (Italy)

^d UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Loco regional therapy; Milan criteria; Outcome; Prediction; Recurrence; Selection

Indexed keywords

ALPHA FETOPROTEIN;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER SIZE; CANCER SURVIVAL; DISEASE FREE SURVIVAL; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORPHOLOGY; PARAMETERS; PATIENT SELECTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURVIVAL RATE;

ADULT; AGED; ALPHA-FETOPROTEINS; CARCINOMA, HEPATOCELLULAR; FEMALE; HUMANS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PATIENT SELECTION; WAITING LISTS;

EID: 84859861407     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2011.01572.x     Document Type: Article

References (29)

1. Mazzaferro V, Regalia E, Doci R et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996: 334: 693.
2. Rossi M, Merli M, Lai Q et al. Outcome after liver transplantation in patients with cirrhosis and hepatocellular carcinoma. Transpl Proc 2007: 39: 1895.
3. Llovet JM, Fuster J, Bruix J. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology 1999: 30: 1434.
4. Yao FY, Ferrell L, Bass NM et al. Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology 2001: 33: 1394.
5. Herrero JI, Sangro B, Quiroga J et al. Influence of tumor characteristics on the outcome of liver transplantation among patients with liver cirrhosis and hepatocellular carcinoma. Liver Transpl 2001: 7: 631.
6. Merli M, Nicolini G, Gentili F et al. Predictive factors of outcome after liver transplantation in patients with cirrhosis and hepatocellular carcinoma. Transpl Proc 2005: 37: 2535.
7. Onaca N, Davis GL, Goldstein RM, Jennings LW, Klintmalm GB. Expanded criteria for liver transplantation in patients with hepatocellular carcinoma: a report from the International Registry of Hepatic Tumors in Liver Transplantation. Liver Transpl 2007: 13: 391.
8. Sugawara Y, Tamura S, Makuuchi M. Living donor liver transplantation for hepatocellular carcinoma: Tokyo University series. Dig Dis 2007: 25: 310.
9. Takada Y, Ito T, Ueda M et al. Living donor liver transplantation for patients with HCC exceeding the Milan criteria: a proposal of expanded criteria. Dig Dis 2007: 25: 299.
10. Ito T, Takada Y, Ueda M et al. Expansion of selection criteria for patients with hepatocellular carcinoma in living donor liver transplantation. Liver Transpl 2007: 13: 1637.
11. Lee SG, Hwang S, Moon DB et al. Expanded indication criteria of living donor liver transplantation for hepatocellular carcinoma at one large-volume centre. Liver Transpl 2008: 14: 935.
12. Silva M, Moya A, Berenguer M et al. Expanded criteria for liver transplantation in patients with cirrhosis and hepatocellular carcinoma. Liver Transpl 2008: 14: 1449.
13. Toso C, Trotter J, Wei A et al. Total tumor volume predicts risk of recurrence following liver transplantation in patients with hepatocellular carcinoma. Liver Transpl 2008: 14: 1107.
14. Cillo U, Vitale A, Bassanello M et al. Liver transplantation for the treatment of moderately or well-differentiated hepatocellular carcinoma. Ann Surg 2004: 239: 150.
15. Kwon CH, Kim DJ, Han YS et al. HCC in living donor liver transplantation: can we expand the Milan criteria? Dig Dis 2007: 25: 313.
16. Zheng SS, Xu X, Wu J et al. Liver transplantation for hepatocellular carcinoma: Hangzhou experiences. Transplantation 2008: 85: 1726.
17. Toso C, Asthana S, Bigam DL, Shapiro AM, Kneteman NM. Reassessing selection criteria prior to liver transplantation for hepatocellular carcinoma utilizing the scientific registry of transplant recipients database. Hepatology 2009: 49: 832.
18. Mazzaferro V, Llovet JM, Miceli R et al. Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. Lancet Oncol 2009: 10: 35.
19. Bruix J, Sherman M, Llovet JM et al. Clinical management on hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. J Hepatol 2001: 35: 421.
20. Therasse P, Arbuck SG, Eisenhauer EA et al. New guidelines to evaluate the response to treatment in solid tumors (RECIST Guidelines). J Natl Cancer Inst 2000: 92: 205.
21. Edmondson HA, Steiner PE. Primary carcinoma of the liver: a study of 100 cases among 48, 900 necropsies. Cancer 1954: 7: 462.
22. Berga CL, Steffick DE, Edwardsd EB et al. Liver and Intestine Transplantation in the United States 1998-2007. Am J Transplant 2009: 9: 907.
23. Ioannou GN, Perkins JD, Carithers RL Jr. Liver transplantation for hepatocellular carcinoma: impact of the MELD allocation system and predictors of survival. Gastroenterology 2008: 134: 1342.
24. Mchugh PP, Gilbert J, Vera S, Koch A, Ranjan D, Gedaly R. Alpha-fetoprotein and tumour size are associated with microvascular invasion in explanted livers of patients undergoing transplantation with hepatocellular carcinoma. HPB 2010: 12: 56.
25. Duvoux C, Decaens T, Pessione F et al. Pre-transplant AFP level is a simple and useful test for a controlled expansion of Milan criteria in liver transplant candidates for hepatocellular carcinoma. J Hepat 2010: 52: S51.
26. Yang SH, Suh KS, Lee HW et al. A revised scoring system utilizing serum alphafetoprotein levels to expand candidates for living donor transplantation in hepatocellular carcinoma. Surgery 2007: 141: 598.
27. Cillo U, Navaglia F, Vitale A et al. Clinical significance of alpha-fetoprotein mRNA in blood of patients with hepatocellular carcinoma. Clin Chim Acta 2004: 347: 129.
28. Cillo U, Vitale A, Navaglia F et al. Role of blood AFP mRNA and tumor grade in the preoperative prognostic evaluation of patients with hepatocellular carcinoma. World J Gastroenterol 2005: 11: 6920.
29. Vibert E, Azoulay D, Hoti E et al. Progression of alphafetoprotein before liver transplantation for hepatocellular carcinoma in cirrhotic patients: a critical factor. Am J Transplant 2010: 10: 129.